Erlotinib Unknown Status Phase N/A Trials for EGFR Mutation Positive Non-small Cell Lung Cancer Diagnostic

IndicationsStatusPurposePhase
Unknown StatusDiagnosticNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT01776684Evaluation of EGFR TKI Resistance Mechanism Using Plasma DNA Analysis